Adaptive Biotechnologies Corporation · NASDAQ:ADPT
Rubinstein Julie sold 38,120 Adaptive Biotechnologies Corporation shares (Form 4)
Traded Apr 1 to Apr 2, 2026 · Filed Apr 2, 2026
From Apr 1 to Apr 2, 2026, Rubinstein Julie (President and COO) sold 38,120 Adaptive Biotechnologies Corporation shares at an average US$14.53 for US$554K under a trading plan, leaving 447,202 shares. Filed Apr 2, 2026 (Form 4).
- Sold
- 38,120 shares
- Price
- US$14.53 average (US$14.45 to US$14.60)
- Value
- US$554K
- Holding after
- 447,202 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- President and COO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 1, 2026 | Common Stock | Option exercise | 14,722 | US$7.27 | 470,600 | Direct |
| Apr 1, 2026 | Common Stock | Sale | 19,060 | US$14.45 | 451,540 | Direct |
| Apr 2, 2026 | Common Stock | Option exercise | 14,722 | US$7.27 | 466,262 | Direct |
| Apr 2, 2026 | Common Stock | Sale | 19,060 | US$14.60 | 447,202 | Direct |
Source
Related
- Adaptive Biotechnologies Corporation
- Rubinstein Julie
- Adaptive Biotechnologies Corporation shareholders
- Form 4 · Rubinstein Julie · Oct 16, 2026
- Form 4 · Rubinstein Julie · Oct 13, 2026
- Form 4 · Rubinstein Julie · Oct 8, 2026
- Form 4 · Rubinstein Julie · Oct 5, 2026
- Form 4 · Rubinstein Julie · Apr 29, 2026
- Form 4 · Bobulsky Susan · Oct 8, 2026
- Form 4 · Lo Francis · Oct 5, 2026
- Form 4 · Lo Francis · Sep 18, 2026
- Schedule 13G/A · Viking Global Investors LP · May 15, 2026
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026